RACHAEL FREEMAN: Open Payments
NPI 1770199978 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 26 payments from 8 companies in 2025. Trend: 2023 $364 · 2024 $458 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $203 |
| Biogen, Inc. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Astellas Pharma US Inc | 3 | $47 |
| Organon LLC | 2 | $33 |
| MILLICENT US INC | 1 | $23 |
| Exact Sciences Corporation | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $13 |
Products named: QULIPTA, UBRELVY, ZURZUVAE, Veozah, Lynkuet, NEXPLANON, FEMRING, Mirena.
Industry payments across VA — which companies pay providers there.
